Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells
- 1 January 2008
- journal article
- case report
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 19 (1) , 55-64
Abstract
Norcantharidin (NCTD), a chemically modified form of cantharidin, is a potential anticancer drug. This study investigated the effect of NCTD on anoikis in CT26 colorectal adenocarcinoma cells. NCTD treatment of CT26 cells showed a dose-dependent and time-dependent decrease in viability and cell proliferation. Growth inhibition was accompanied by cell cycle arrest in the S and G2/M phases. Mitogen-activated protein kinase expression, assayed by Western blot, was unchanged except for Jun-N-terminal kinase (JNK). At 24 h of treatment with 0–20 μmol/l NCTD, JNK expression increased at 24 h, but then decreased at 48 h; in contrast, the phosphorylated JNK levels markedly increased. JNK inhibitor (SP600125) in the culture effectively blocked NCTD-induced cytotoxicity and detachment of cells. CT26 cells treated with NCTD not only displayed inhibited cell adhesion and down-expression of integrin β1, but also changed from being shuttle-shaped to round, the latter cells being more susceptible to anoikis-mediated apoptosis. Flow cytometric assay of the DNA content in NCTD-treated CT26 cells at 24 and 48 h showed a marked increase in the sub-G1 level, indicating that NCTD induced apoptosis. NCTD inhibited the viability of CT26 cancer cells preferentially over normal bone marrow and mononuclear cells. NCTD inhibits CT26 cancer cells by blocking proliferation and inducing anoikis-mediated apoptosis, a process that might be regulated by JNK activation.Keywords
This publication has 33 references indexed in Scilit:
- Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cellsAnti-Cancer Drugs, 2006
- Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): Implications for the binding modeBioorganic & Medicinal Chemistry, 2005
- In vitro Assessment of Renal Toxicity and Inflammatory Events of Two Protein Phosphatase Inhibitors Cantharidin and Nor‐Cantharidin*Basic & Clinical Pharmacology & Toxicology, 2005
- Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cellsWorld Journal of Gastroenterology, 2005
- An Investigation on Liver-Targeting Microemulsions of NorcantharidinDrug Delivery, 2005
- Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytesOral Oncology, 2003
- Effector mechanisms of norcantharidin‐induced mitotic arrest and apoptosis in human hepatoma cellsInternational Journal of Cancer, 2002
- Effect of Norcantharidin on N-acetyltransferase Activity in HepG2 CellsThe American Journal of Chinese Medicine, 2001
- Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survivalCancer Letters, 1997
- Medical uses of mylabris in ancient China and recent studiesJournal of Ethnopharmacology, 1989